TW202128028A - Food composition comprising low-glycosides ginsenoside using hydroponically grown ginseng leaf and preparation method thereof - Google Patents
Food composition comprising low-glycosides ginsenoside using hydroponically grown ginseng leaf and preparation method thereof Download PDFInfo
- Publication number
- TW202128028A TW202128028A TW109135060A TW109135060A TW202128028A TW 202128028 A TW202128028 A TW 202128028A TW 109135060 A TW109135060 A TW 109135060A TW 109135060 A TW109135060 A TW 109135060A TW 202128028 A TW202128028 A TW 202128028A
- Authority
- TW
- Taiwan
- Prior art keywords
- ginseng
- ginsenoside
- leaves
- glycoside
- content
- Prior art date
Links
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 164
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 162
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 161
- 229930182494 ginsenoside Natural products 0.000 title claims abstract description 87
- 229940089161 ginsenoside Drugs 0.000 title claims abstract description 60
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241000208340 Araliaceae Species 0.000 title claims abstract 25
- 235000013305 food Nutrition 0.000 title abstract description 15
- 239000000203 mixture Substances 0.000 title abstract description 13
- 238000010025 steaming Methods 0.000 claims abstract description 50
- 238000000034 method Methods 0.000 claims abstract description 31
- 238000001035 drying Methods 0.000 claims abstract description 15
- 239000012141 concentrate Substances 0.000 claims description 52
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 claims description 20
- BGHNZAWRRWLKPO-UHFFFAOYSA-N Ginsenoside F1 Natural products CC(=C)CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C BGHNZAWRRWLKPO-UHFFFAOYSA-N 0.000 claims description 8
- XNGXWSFSJIQMNC-FIYORUNESA-N ginsenoside F1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@H](O)[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XNGXWSFSJIQMNC-FIYORUNESA-N 0.000 claims description 8
- FVIZARNDLVOMSU-IRFFNABBSA-N ginsenoside C-K Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FVIZARNDLVOMSU-IRFFNABBSA-N 0.000 claims description 7
- CKUVNOCSBYYHIS-IRFFNABBSA-N (20S)-ginsenoside Rh2 Chemical compound O([C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CKUVNOCSBYYHIS-IRFFNABBSA-N 0.000 claims description 6
- PHLXREOMFNVWOH-YAGNRYSRSA-N Ginsenoside Rh3 Chemical compound O([C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4C(\C)=C/CC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PHLXREOMFNVWOH-YAGNRYSRSA-N 0.000 claims description 6
- WMGBQZAELMGYNO-YMWSGFAJSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[[(3s,5r,8r,9r,10r,12r,13r,14r,17s)-12-hydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol Chemical compound O([C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4C(=C)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WMGBQZAELMGYNO-YMWSGFAJSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 abstract description 9
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 description 139
- 235000002789 Panax ginseng Nutrition 0.000 description 35
- 229930182470 glycoside Natural products 0.000 description 15
- 150000002338 glycosides Chemical class 0.000 description 15
- 230000000694 effects Effects 0.000 description 13
- 229930182490 saponin Natural products 0.000 description 9
- 235000017709 saponins Nutrition 0.000 description 9
- 150000007949 saponins Chemical class 0.000 description 9
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000002087 whitening effect Effects 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- -1 lipid peroxides Chemical class 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 150000003648 triterpenes Chemical class 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000012364 cultivation method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- BBEUDPAEKGPXDG-UHFFFAOYSA-N protopanaxatriol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC3C4(C)CCC(O)C(C)(C)C4C(O)CC23C BBEUDPAEKGPXDG-UHFFFAOYSA-N 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- PYXFVCFISTUSOO-HKUCOEKDSA-N (20S)-protopanaxadiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C PYXFVCFISTUSOO-HKUCOEKDSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- PYXFVCFISTUSOO-UHFFFAOYSA-N betulafolienetriol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC(C(C)(O)CCC=C(C)C)C4C(O)CC3C21C PYXFVCFISTUSOO-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- SWQINCWATANGKN-UHFFFAOYSA-N protopanaxadiol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3CCC21C SWQINCWATANGKN-UHFFFAOYSA-N 0.000 description 2
- SHCBCKBYTHZQGZ-DLHMIPLTSA-N protopanaxatriol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2[C@@H](O)C[C@@]3(C)[C@]4(C)CC[C@H]([C@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C SHCBCKBYTHZQGZ-DLHMIPLTSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 241000168720 Panax japonicus Species 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003627 anti-cholesterol Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical group N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
- A01G31/00—Soilless cultivation, e.g. hydroponics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/40—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/10—General methods of cooking foods, e.g. by roasting or frying
- A23L5/13—General methods of cooking foods, e.g. by roasting or frying using water or steam
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/50—Concentrating, enriching or enhancing in functional factors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Environmental Sciences (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
本發明涉及含使用水耕栽培人參葉的低醣苷人參皂苷的食品組合物,更詳細地,涉及藉由包括對水耕栽培人參葉進行蒸熟處理的步驟來製備低醣苷人參皂苷含量增加的人參葉濃縮液的方法,以及由此製備的人參葉濃縮液以及食品組合物。The present invention relates to a food composition containing low-glycosides ginsenosides using hydroponic cultivated ginseng leaves. More specifically, it relates to the preparation of low-glycosides ginsenosides with increased content of ginseng by including a step of steaming the hydroponic cultivated ginseng leaves Method for leaf concentrate, ginseng leaf concentrate and food composition prepared thereby.
人參(Panax ginseng C. A. Meyer)是非常高性能的藥用作物,在韓國正在積極栽培。在過去數十年間,隨著諸如肥料以及殺蟲劑的應用等耕作技術的發展,人參產量一直不斷增長。在商業方面,人參的根被認為是主要交易部分,而對於人參葉,由於被認為是副產物,因此在人參根的收穫過程中經常被廢棄。Ginseng (Panax ginseng C. A. Meyer) is a very high-performance medicinal material and is actively cultivated in Korea. In the past few decades, with the development of farming techniques such as the application of fertilizers and pesticides, the production of ginseng has been increasing. In terms of business, the root of ginseng is considered to be the main transaction part, while ginseng leaves are often discarded during the harvesting process because they are considered to be by-products.
人參皂苷(Ginsenoside)是人參中的三萜(Triterpene)皂苷,皂苷在化學上是醣苷(Glycoside)化合物的一種,存在於人參的根、莖、葉、皮、種子等中,以前被認為是非營養物質,但最近隨著顯示抗癌、抗氧化、膽固醇降低效果,開始作為生理活性物質而備受關注。Ginsenoside (Ginsenoside) is a triterpene (Triterpene) saponin in ginseng. Saponins are chemically a kind of glycoside (Glycoside) compounds. They exist in the roots, stems, leaves, skins, seeds, etc. of ginseng. They were previously considered non-nutritive However, recently it has shown anti-cancer, anti-oxidation, and cholesterol-lowering effects, and has begun to attract attention as a physiologically active substance.
在韓藥中,一直被用作強心劑或利尿劑,特別是,在人參的各種有效成分中,起主要藥理作用的是皂苷。人參皂苷具有獨特化學結構,與其他植物中發現的皂苷不同,藥理功效也獨特,因此作為人參(Ginseng)醣苷(Glycoside)的含義,被稱為「人參皂苷(Ginsenoside)」。In Korean medicine, it has been used as a cardiotonic or diuretic. In particular, among the various active ingredients of ginseng, saponins play a major pharmacological role. Ginseng saponins have a unique chemical structure and are different from the saponins found in other plants. They also have unique pharmacological effects. Therefore, as the meaning of Ginseng glycoside (Glycoside), it is called "Ginsenoside".
最近,進行多種研究發現,人參葉中也含有多種人參皂苷,並且為了使用葉中存在的人參皂苷提純物,正在與根的人參皂苷進行比較研究。Recently, various studies have been conducted and found that ginseng leaves also contain a variety of ginsenosides, and in order to use the ginsenoside extract present in the leaves, a comparative study is being conducted with the root ginsenosides.
在丟棄的葉中也提純出特定的人參皂苷,因此可以期待健康食品乃至醫藥品用途的經濟商品。人參皂苷可分為諸如原人參二醇(Protopanaxadiol,PPD)乃至原人參三醇(Protopanaxatriol,PPT)醣苷配基(Aglycon)形式等三萜烯型和齊墩果酸型。形成含有醣苷之醣苷配基的人參皂苷,可以藉由醣苷的釋放而轉化為其他形式的人參皂苷。這種轉化可由熱、酸分解、酶處理引起。Specific ginsenosides are also purified from discarded leaves, so economic products for health foods and even pharmaceuticals can be expected. Ginsenosides can be divided into triterpene type and oleanolic acid type such as Protopanaxadiol (PPD) and even Protopanaxatriol (Protopanaxatriol, PPT) aglycon form. Ginsenosides that form aglycone containing glycosides can be converted into other forms of ginsenosides by the release of glycosides. This conversion can be caused by heat, acid decomposition, and enzyme treatment.
已知人參葉的粗皂苷含量為19.58%,與莖(2.38%)或根(4.78%)相比,含量較高,並且人參葉的人參皂苷含量為10.84%,與莖(0.64%)以及根(2.37%)相比,含量較高(Korean J.Ginseng Sci. 11(2). 118-112, 1987)。另外,人參皂苷中存在多種形式的成分,並且顯示出各自不同的功效,因此一直是研究的主要目標。 Rb1:參與胚胎發育、骨髓細胞的DNA(RNA-脂質合成、促進作用)、藉由促進性激素生成來影響生殖系統 Rc:鎮痛作用、促進蛋白質以及脂質合成 Rb2:抗糖尿病作用、免疫調節作用、膽固醇代謝 Rb3:生理活性 Rd:促進腎上腺皮質激素分泌的作用 Rg3:抑制癌細胞轉移的作用、抑制血小板聚集、抑制抗癌劑耐性的作用 Rh2:抑制癌細胞增殖、抑制腫瘤增殖、皮膚免疫效果It is known that the crude saponin content of ginseng leaves is 19.58%, which is higher than that of stems (2.38%) or roots (4.78%), and the content of ginsenosides of ginseng leaves is 10.84%, which is higher than that of stems (0.64%) and roots. (2.37%), the content is higher (Korean J. Ginseng Sci. 11(2). 118-112, 1987). In addition, there are many forms of ginsenosides, and they show different effects, so they have been the main goal of research. Rb1: Participate in embryonic development, DNA of bone marrow cells (RNA-lipid synthesis, promotion), and affect the reproductive system by promoting the production of sex hormones Rc: Analgesic effect, promote protein and lipid synthesis Rb2: Anti-diabetic effect, immune regulation effect, cholesterol metabolism Rb3: physiological activity Rd: Promote the secretion of adrenal cortex hormones Rg3: Inhibition of cancer cell metastasis, inhibition of platelet aggregation, and inhibition of anticancer drug resistance Rh2: Inhibit cancer cell proliferation, inhibit tumor proliferation, skin immune effect
根據迄今為止報導過的許多研究,已知在加工並使用植物的過程中,隨著乾燥條件,內在的功能性物質轉化為其他物質或者在溶出時帶來溶出含量的變化。對人參葉的人參皂苷分析的研究活躍度遠不如根,特別是,對諸如熱處理等加工造成的影響進行研究的例子並不多。因此,實情是需要嘗試利用人參葉的有用成分。迄今為止,實情是還沒有藉由使用蒸熟來改變諸如人參葉等草藥內功能性的傳統技術。According to many studies reported so far, it is known that in the process of processing and using plants, with drying conditions, inherent functional substances are transformed into other substances or the dissolution content changes during dissolution. Research on the analysis of ginsenosides in ginseng leaves is far less active than roots. In particular, there are not many examples of studies on the effects of processing such as heat treatment. Therefore, it is necessary to try to use the useful ingredients of ginseng leaves. So far, the truth is that there is no traditional technique that uses steaming to change the functionality of herbs such as ginseng leaves.
在此背景下,本發明人為了增加低醣苷人參皂苷的含量而不斷研究的結果,確認了當使用水耕栽培人參葉來進行蒸熟過程時,低醣苷人參皂苷的含量增加,並且可以製備包含其的人參葉濃縮液,從而完成了本發明。In this context, the inventors of the present invention have conducted continuous research to increase the content of low-glycosides ginsenosides, confirming that when hydroponic cultivated ginseng leaves are used for the steaming process, the content of low-glycosides ginsenosides increases and can be prepared to contain Its ginseng leaf concentrate has completed the present invention.
[現有技術文獻][Prior Art Literature]
[專利文獻] (專利文獻1)韓國授權專利10-0325778[Patent Literature] (Patent Document 1) Korean granted patent 10-0325778
技術課題Technical issues
本發明的一個目的是提供一種使1-醣苷人參皂苷(1-glycoside ginsenoside)含量增加的人參葉濃縮液的製備方法,包括對去除水分的水耕栽培人參葉進行蒸熟處理的步驟;對上述蒸熟處理的人參葉進行乾燥並粉碎的步驟;以及對上述乾燥及粉碎的人參葉進行提取而濃縮的步驟。An object of the present invention is to provide a method for preparing a ginseng leaf concentrate with increased content of 1-glycoside ginsenoside, which includes the step of steaming hydroponic ginsenoside leaves from which water has been removed; The step of drying and crushing the steamed ginseng leaves; and the step of extracting and concentrating the dried and crushed ginseng leaves.
本發明的另一目的是提供一種製備人參葉濃縮液時增加1-醣苷人參皂苷含量的方法,包括對去除水分的水耕栽培人參葉進行蒸熟處理的步驟;對上述蒸熟處理的人參葉進行乾燥並粉碎的步驟;以及對上述乾燥及粉碎的人參葉進行提取而濃縮的步驟。Another object of the present invention is to provide a method for increasing the content of 1-glycoside ginsenoside when preparing ginseng leaf concentrate, including the step of steaming the hydroponic ginseng leaves from which water has been removed; and the above-mentioned steamed ginseng leaves A step of drying and crushing; and a step of extracting and concentrating the dried and crushed ginseng leaves.
本發明的又一目的是提供一種藉由上述製備方法製備的人參葉濃縮液。Another object of the present invention is to provide a ginseng leaf concentrate prepared by the above preparation method.
課題解决手段Problem solving methods
具體說明如下。另一方面,本發明中公開的說明以及實施方式也可適用於其他說明以及實施方式。即,本發明中公開的多種要素的所有組合均屬於本發明的範疇。另外,不認為本發明的範疇由以下記載的具體描述限制。The specific description is as follows. On the other hand, the descriptions and embodiments disclosed in the present invention can also be applied to other descriptions and embodiments. That is, all combinations of various elements disclosed in the present invention belong to the scope of the present invention. In addition, it is not considered that the scope of the present invention is limited by the specific description described below.
作為實現上述目的的一個方面,提供一種使1-醣苷人參皂苷含量增加的人參葉濃縮液的製備方法,包括對去除水分的水耕栽培人參葉進行蒸熟處理的步驟、對上述蒸熟處理的人參葉進行乾燥並粉碎的步驟以及對上述乾燥及粉碎的人參葉進行提取而濃縮的步驟。As one aspect of achieving the above-mentioned object, a method for preparing a ginseng leaf concentrate with increased content of 1-glycoside ginsenoside is provided. The step of drying and crushing ginseng leaves and the step of extracting and concentrating the dried and crushed ginseng leaves.
作為實現上述目的的另一方面,提供一種製備人參葉濃縮液時增加1-醣苷人參皂苷含量的方法,包括對去除水分的水耕栽培人參葉進行蒸熟處理的步驟、對上述蒸熟處理的人參葉進行乾燥並粉碎的步驟以及對上述乾燥及粉碎的人參葉進行提取而濃縮的步驟。As another aspect of achieving the above objective, there is provided a method for increasing the content of 1-glycoside ginsenoside when preparing ginseng leaf concentrate, which includes the step of steaming the hydroponic ginseng leaves from which water has been removed, and the method of steaming the above-mentioned steaming treatment. The step of drying and crushing ginseng leaves and the step of extracting and concentrating the dried and crushed ginseng leaves.
作為實現上述目的的又一方面,本發明提供一種藉由上述製備方法製備的人參葉濃縮液。As another aspect of achieving the above-mentioned object, the present invention provides a ginseng leaf concentrate prepared by the above-mentioned preparation method.
具體而言,本發明提供低醣苷人參皂苷(1-醣苷人參皂苷)含量增加的人參葉濃縮液,並且人參葉濃縮液可以作為皮膚美白用、黑斑改善用食品組合物而提供。Specifically, the present invention provides a ginseng leaf concentrate having an increased content of low-glycoside ginsenoside (1-glycoside ginsenoside), and the ginseng leaf concentrate can be provided as a food composition for skin whitening and dark spot improvement.
人參作為僅在亞洲遠東地區自生的藥用植物,是一種具有優異的強壯效果,並且含有被稱為皂苷的藥用成分,而具有抗癌、抗氧化、美白、膽固醇降低效果以及對各種疾病具有治療效果的植物。通常,人參在露地栽培4年以上,並且大多使用4年根以及6年根。然而,這種露地栽培方式具有以下缺點:需要較長的時間並且存在空間限制。因此,本發明使用在由水和水溶性營養成分製成的培養液中培養人參的方法,即水耕栽培。As a medicinal plant that regenerates itself only in the Far East of Asia, ginseng is a kind of excellent strong effect, and contains medicinal ingredients called saponin, and has anti-cancer, anti-oxidation, whitening, cholesterol-lowering effects and has a variety of diseases. Plants with therapeutic effects. Generally, ginseng is cultivated in the open field for more than 4 years, and the 4-year-old root and the 6-year-old root are mostly used. However, this open field cultivation method has the following disadvantages: it takes a long time and has space limitations. Therefore, the present invention uses a method of cultivating ginseng in a culture solution made of water and water-soluble nutrients, that is, hydroponic cultivation.
藉由水耕栽培培養的人參沒有農藥等有害物質,因此不僅可以使用人參根,還可以使用葉和莖等所有部分。另外,與露地栽培的人參葉相比,水耕栽培的人參葉可以實現更高的人參皂苷含量。Ginseng cultivated by hydroponic cultivation has no harmful substances such as pesticides, so not only the root of ginseng can be used, but also all parts such as leaves and stems can be used. In addition, hydroponic cultivated ginseng leaves can achieve a higher ginsenoside content than ginseng leaves cultivated in the open field.
人參皂苷是指人參所含的皂苷。皂苷源自拉丁語Sapo(皂),作為震盪於水後產生持久性的泡沫的天然表面活性物質,是在植物界中廣泛分布的三萜以及類固醇系醣苷的總稱。具有與膽固醇相似的化學結構,因此抑制吸收膽固醇並且也幫助排出。如果長期攝取肉類等的動物性食品,體內會產生類似於氧化的脂肪塊的過氧化脂質,這是致癌因素之一。人參皂苷可以藉由分解過氧化脂質,切斷癌症的根源、阻止自由基對細胞的破壞並且抑制突變,從而特別是降低結腸癌的發生概率。另外,減少積累到體內脂肪的能量是其固有作用之一,動物實驗結果,甚至具有從根本上改善肥胖體質的功能。Ginsenoside refers to the saponins contained in ginseng. Saponins are derived from the Latin word Sapo (soap), which is a natural surface active substance that produces a lasting foam after being shaken in water. It is a general term for triterpenoids and steroid glycosides widely distributed in the plant kingdom. It has a chemical structure similar to cholesterol, so it inhibits the absorption of cholesterol and also helps excrete it. If you eat meat and other animal foods for a long time, the body will produce lipid peroxides similar to oxidized fat, which is one of the carcinogenic factors. Ginsenosides can decompose lipid peroxides, cut off the root cause of cancer, prevent free radicals from destroying cells and inhibit mutations, thereby reducing the incidence of colon cancer in particular. In addition, reducing the energy accumulated in body fat is one of its inherent effects. The results of animal experiments even have the function of fundamentally improving obesity.
另外,為了攝取人參的藥用成分,通常加工成醫藥品或健康食品等的形式,但現有的人參飲料以及食品僅使用人參根,幾乎不使用人參的葉和莖。然而,由於人參葉和莖中含有大量的人參皂苷成分,因此本發明使用了人參葉。In addition, in order to ingest the medicinal components of ginseng, it is usually processed into the form of medicines or health foods, but existing ginseng drinks and foods only use ginseng roots, and hardly use ginseng leaves and stems. However, since ginseng leaves and stems contain a large amount of ginsenoside components, the present invention uses ginseng leaves.
另外,本發明中使用的人參葉,人參的特徵在於,可以為高麗參(Panax ginseng)或花旗參(Panax quinquefolius),但不限於此。In addition, the ginseng leaves used in the present invention are characterized in that they can be Panax ginseng or Panax quinquefolius, but are not limited thereto.
在本發明中,上述水耕栽培人參葉可以較佳地為1年生至3年生。In the present invention, the above-mentioned hydroponic cultivated ginseng leaves may preferably be 1 to 3 years old.
本發明的術語「醣苷(glycoside)」作為植物界中廣泛分布的成分之一,是指在酸、鹼或適當的水解酶的作用下分解成糖部分和被稱為苷元或配基的非糖部分的物質的總稱,並且當人參皂苷被體內吸收時,醣苷(glycoside)被釋放並以低醣苷吸收,並且藉由增加低醣苷,可以增加體內吸收率。The term "glycoside" in the present invention, as one of the widely distributed components in the plant kingdom, means that it is decomposed into sugar moieties and non-glycosides called aglycons or ligands under the action of acids, bases or appropriate hydrolytic enzymes. The general term for substances in the sugar part. When ginsenosides are absorbed by the body, glycosides are released and absorbed as low-glycosides, and by increasing low-glycosides, the absorption rate in the body can be increased.
在本發明中,上述蒸熟是指藉由蒸而進行熟成,具體而言,在本發明中,可以進行蒸熟處理步驟以增加所需低醣苷人參皂苷的含量。在本發明中,上述蒸熟處理的步驟不限於此,但可以進行4小時以上,具體而言,可以較佳地進行4小時至6小時,更具體地,可以進行5小時。In the present invention, the above-mentioned steaming refers to aging by steaming. Specifically, in the present invention, a steaming treatment step may be performed to increase the content of the required low-glycoside ginsenoside. In the present invention, the step of the above-mentioned steaming treatment is not limited to this, but can be carried out for more than 4 hours, specifically, it can be carried out preferably for 4 hours to 6 hours, and more specifically, it can be carried out for 5 hours.
如果上述蒸熟處理的步驟小於4小時,則增加人參皂苷含量的效果可能略小。If the above-mentioned steaming treatment step is less than 4 hours, the effect of increasing the ginsenoside content may be slightly less.
另外,上述蒸熟處理的步驟不限於此,但可以在90℃至110℃下進行,具體而言,可以在95℃至105℃下進行。在本發明的一個實施例中,在98℃下進行了蒸熟處理。In addition, the step of the above-mentioned steaming treatment is not limited to this, but can be carried out at 90°C to 110°C, specifically, it can be carried out at 95°C to 105°C. In an embodiment of the present invention, the steaming treatment is carried out at 98°C.
在本發明中,上述乾燥的步驟不限於此,但可以較佳地藉由在50℃至70℃下乾燥10小時至100小時來使上述人參葉的水分介於1%至15%。In the present invention, the above-mentioned drying step is not limited to this, but the moisture content of the above-mentioned ginseng leaves may be between 1% and 15% by drying at 50°C to 70°C for 10 hours to 100 hours.
具體而言,可以更佳地在60℃的乾燥箱中乾燥12小時直至人參葉的水分達到15%。Specifically, it can be dried in a drying oven at 60°C for 12 hours until the moisture content of the ginseng leaves reaches 15%.
乾燥時間可以根據乾燥溫度以及其他條件而變化,並且較佳地,可以乾燥至人參葉水分為15%以下。The drying time can be changed according to the drying temperature and other conditions, and preferably, it can be dried until the moisture of the ginseng leaf is 15% or less.
在本發明中,上述提取而濃縮的步驟不限於此,但可以較佳地藉由添加醇來進行提取。In the present invention, the above-mentioned extraction and concentration step is not limited to this, but it may preferably be extracted by adding alcohol.
上述醇的濃度不限於此,但可以為60%至80%。The concentration of the above alcohol is not limited to this, but may be 60% to 80%.
上述提取的步驟不限於此,但可以較佳地提取7小時至9小時。The above extraction step is not limited to this, but it may preferably be extracted for 7 hours to 9 hours.
上述減壓而濃縮的步驟不限於此,但可以濃縮至65%至90%白利糖度(Brix)。The step of concentration under reduced pressure is not limited to this, but it can be concentrated to 65% to 90% Brix.
上述低醣苷人參皂苷不限於此,但可以是1-醣苷人參皂苷,具體而言,可以是包括人參皂苷F1、化合物K、Rh2、Rh3和/或Rk2的那些。The aforementioned low-glycoside ginsenosides are not limited thereto, but may be 1-glycoside ginsenosides, specifically, those including ginsenoside F1, compound K, Rh2, Rh3, and/or Rk2.
與乾紅參、紅參濃縮液、乾人參葉、乾人參莖、蒸熟處理的紅參、蒸熟處理的人參莖相比,藉由本發明的製備方法製備的人參葉濃縮液可以實現低醣苷人參皂苷含量的增加。Compared with dried red ginseng, red ginseng concentrate, dried ginseng leaves, dried ginseng stems, steamed red ginseng, and steamed ginseng stems, the ginseng leaf concentrate prepared by the preparation method of the present invention can achieve low glycoside Increase in ginsenoside content.
本發明的人參葉濃縮液藉由增加低醣苷人參皂苷的含量來抑制皮膚變黑,從而可以作為皮膚美白用以及黑斑改善用食品組合物而提供。The ginseng leaf concentrate of the present invention suppresses skin darkening by increasing the content of low-glycoside ginsenosides, and can be provided as a food composition for skin whitening and dark spot improvement.
上述食品組合物不僅可以含有本發明的人參葉濃縮液,還可以含有各種營養劑、維生素、電解質、風味劑、著色劑、甜味劑、酸味劑、果膠酸及其鹽、海藻酸及其鹽、有機酸、保護性膠體增稠劑、pH調節劑、穩定劑、防腐劑、甘油、用於酒精碳酸飲料的碳酸化劑等。The above food composition may not only contain the ginseng leaf concentrate of the present invention, but also various nutrients, vitamins, electrolytes, flavors, colorants, sweeteners, sour agents, pectic acid and its salts, alginic acid and its Salts, organic acids, protective colloid thickeners, pH adjusters, stabilizers, preservatives, glycerin, carbonating agents for alcoholic carbonated beverages, etc.
上述食品組合物包含的包括人參葉濃縮液在內的所有成分,較佳地為,不超過食品準則(韓國規定)、食品添加物準則(韓國規定)、健康功能食品準則(韓國規定)、中國衛生規範(中國規定)等所規定的最大使用值。The above-mentioned food composition contains all ingredients including ginseng leaf concentrate, preferably, not exceeding the food guidelines (South Korea regulations), food additives guidelines (South Korea regulations), health functional food guidelines (South Korea regulations), China The maximum use value stipulated by the sanitary regulations (Chinese regulations), etc.
發明效果Invention effect
本發明可以提供低醣苷人參皂苷含量增加的人參葉濃縮液。另外,使用水耕栽培的人參葉進行蒸熟過程的本發明的人參葉濃縮液,可以作為皮膚美白用、黑斑改善用食品組合物而提供。The invention can provide a ginseng leaf concentrate with an increased content of low-glycosides and ginsenosides. In addition, the ginseng leaf concentrate of the present invention in which hydroponic ginseng leaves are subjected to a steaming process can be provided as a food composition for skin whitening and dark spot improvement.
在下文中,將藉由實施例更詳細地說明本發明。這些實施例旨在更具體地說明本發明,並且本發明的範圍不限於這些實施例。Hereinafter, the present invention will be explained in more detail through examples. These examples are intended to explain the present invention more specifically, and the scope of the present invention is not limited to these examples.
製備例:製備水耕栽培人參葉濃縮液Preparation example: Preparation of hydroponic cultivated ginseng leaf concentrate
藉由收集水耕栽培的1-3年生人參葉來選擇,並準備新鮮的綠葉。清洗人參葉並去除水分,然後藉由滅菌釜在98℃下蒸熟處理5小時。蒸熟處理後,在60℃的乾燥箱中乾燥12小時以上,以使人參葉的水分為15%以下。使用攪拌機將經乾燥的人參葉粉碎並在室溫下保存。投入70%酒精(醇)8倍,並將經粉碎的人參葉循環提取8小時,然後減壓濃縮至白利糖度(Brix)65%以上,從而獲得濃縮液。Choose by collecting 1-3 year-old ginseng leaves from hydroponic cultivation, and prepare fresh green leaves. Wash the ginseng leaves and remove the water, and then steam them in a sterile autoclave at 98°C for 5 hours. After the steaming treatment, it is dried in a drying cabinet at 60°C for more than 12 hours so that the water content of the ginseng leaves is 15% or less. The dried ginseng leaves were crushed using a blender and stored at room temperature. Put in 70% alcohol (alcohol) 8 times, and circulate the crushed ginseng leaves for 8 hours, and then concentrate under reduced pressure to Brix above 65% to obtain a concentrated liquid.
以相同的方法也應用於紅參、人參莖,從而製備濃縮液。The same method is also applied to red ginseng and ginseng stems to prepare a concentrate.
實施例1:分析經過了蒸熟過程的人參葉的1-醣苷人參皂苷含量Example 1: Analyze the content of 1-glycoside ginsenoside in ginseng leaves that have undergone a steaming process
藉由熱、酶或酸分解,人參皂苷從附著有3-4個糖的形式轉化為1-4個糖釋放的形式。在本發明中,分析1-醣苷人參皂苷(F1、化合物K、Rh2、Rh3、Rk2),從而比較如上所述的蒸熟處理前、後人參皂苷含量變化。By thermal, enzymatic or acid decomposition, ginsenosides are converted from the form with 3-4 sugars attached to the form where 1-4 sugars are released. In the present invention, the 1-glycoside ginsenoside (F1, compound K, Rh2, Rh3, Rk2) is analyzed to compare the changes in the ginsenoside content before and after the steaming treatment as described above.
對於人參皂苷含量,將樣品溶解在70%甲醇中並藉由LC-MS/MS系統(Waters TQ-D system, USA)來進行分析。For the ginsenoside content, the sample was dissolved in 70% methanol and analyzed by the LC-MS/MS system (Waters TQ-D system, USA).
實施例1-1:分析蒸熟處理前人參皂苷含量Example 1-1: Analysis of ginsenoside content before steaming
首先,確認了在紅參以及人參的多種形式中,未經蒸熟處理的1-醣苷人參皂苷含量為多少。具體而言,在對乾紅參、市售的正官庄紅參濃縮液1、市售的豐基人參紅參濃縮液2、乾人參葉或乾人參莖進行蒸熟之前,以乾粉碎物為對象測量了1-醣苷人參皂苷的含量。First, it was confirmed how much the 1-glycoside ginsenoside content of red ginseng and various forms of ginseng has not been steamed. Specifically, before steaming dried red ginseng, the commercially available Zhengguanzhuang red ginseng concentrate 1, the commercially available Fengji ginseng red ginseng concentrate 2, dried ginseng leaves or dried ginseng stems, the dried pulverized matter is the object The content of 1-glycoside ginsenoside was measured.
[表1]
如上表1所示,可以確認與蒸熟前的人參葉以及乾人參莖相比,蒸熟前的乾紅參以及市售的紅參濃縮液1至2中,本發明的1-醣苷人參皂苷(1-glycoside ginsenoside)F1、化合物K、Rh2、Rh3或Rk2的含量低。另外,可以確認在乾人參葉中,人參皂苷F1含量相對較高,為0.983 mg/g,但總體而言,在蒸熟前1-醣苷人參皂苷的含量較低。As shown in Table 1 above, it can be confirmed that the 1-glycoside ginsenoside of the present invention in the dried red ginseng before steaming and the commercially available red ginseng concentrates 1 to 2, compared with the ginseng leaves and dried ginseng stems before steaming The content of (1-glycoside ginsenoside) F1, compound K, Rh2, Rh3 or Rk2 is low. In addition, it can be confirmed that the content of ginsenoside F1 in dried ginseng leaves is relatively high, 0.983 mg/g, but overall, the content of 1-glycoside ginsenoside is low before steaming.
實施例1-2:分析蒸熟處理後人參皂苷含量Example 1-2: Analysis of ginsenoside content after steaming treatment
如上所述,確認了在進行蒸熟處理過程之前,1-醣苷人參皂苷的含量不顯著,並且分析了對多種形式的紅參、人參葉以及人參莖進行蒸熟處理過程後的人參皂苷含量。具體而言,以蒸熟2次至9次紅參、蒸熟1次至2次人參葉以及蒸熟1次至2次人參莖為對象,測量了1-醣苷人參皂苷的含量。As described above, it was confirmed that the content of 1-glycoside ginsenoside was not significant before the steaming process, and the ginsenoside content after the steaming process of various forms of red ginseng, ginseng leaves and ginseng stems was analyzed. Specifically, the content of 1-glycoside ginsenoside was measured by steaming red ginseng 2 to 9 times, steaming ginseng leaves 1 to 2 times, and steaming ginseng stems 1 to 2 times.
[表2]
如上表2所示,確認了即使將紅參蒸熟幾次並將人參莖蒸熟幾次,1-醣苷人參皂苷(1-glycoside ginsenoside)F1、化合物K、Rh2、Rh3或Rk2的含量也不會大幅增加。相反,藉由上表1和上表2的比較,對於進行蒸熟的人參葉,與未進行蒸熟的人參葉相比,1-醣苷人參皂苷(1-glycoside ginsenoside)F1、化合物K、Rh2、Rh3或Rk2的含量顯著增加。As shown in Table 2 above, it was confirmed that even if red ginseng is steamed several times and ginseng stem is steamed several times, the content of 1-glycoside ginsenoside (1-glycoside ginsenoside) F1, compound K, Rh2, Rh3 or Rk2 is not Will increase substantially. On the contrary, according to the comparison of Table 1 and Table 2 above, for the steamed ginseng leaves, compared with the unsteamed ginseng leaves, 1-glycoside ginsenoside (1-glycoside ginsenoside) F1, compound K, Rh2 The content of, Rh3 or Rk2 increased significantly.
實施例2:分析不同栽培方法的人參葉的1-醣苷人參皂苷含量Example 2: Analysis of 1-glycoside ginsenoside content in ginseng leaves of different cultivation methods
如上所述,確認了即使進行蒸熟過程,在紅參或人參莖中也不會有特別的增加,但在人參葉中1-醣苷人參皂苷含量顯著增加,並且旨在藉由改變人參葉的栽培方法來測量人參皂苷含量。As mentioned above, it is confirmed that even if the steaming process is carried out, there will be no special increase in red ginseng or ginseng stems, but the content of 1-glycoside ginsenoside in ginseng leaves is significantly increased. Cultivation method to measure ginsenoside content.
具體而言,以水耕栽培的人參葉和露地栽培的人參葉為對象,進行與上述製備例相同的蒸熟處理來測量人參皂苷含量。Specifically, hydroponic cultivated ginseng leaves and open field cultivated ginseng leaves were used as objects, and the same steaming treatment as the above-mentioned preparation example was performed to measure the ginsenoside content.
如下表3所示,將水耕栽培的1至3年生人參葉以及露地栽培的人參葉在98℃下蒸熟處理5小時,從而測量1-醣苷人參皂苷(1-glycoside ginsenoside)F1、化合物K、Rh2、Rh3或Rk2的含量。As shown in Table 3 below, hydroponic cultivation of 1 to 3 years old ginseng leaves and open field cultivation of ginseng leaves were steamed and treated at 98°C for 5 hours to measure 1-glycoside ginsenoside F1 and compound K , Rh2, Rh3 or Rk2 content.
[表3]
如上表3所示,可以確認,與露地栽培的人參葉相比,水耕栽培的人參葉中1-醣苷人參皂苷的含量更高。因此,可以確認,與露地栽培相比,使用水耕栽培的人參葉可以提高1-醣苷人參皂苷含量。As shown in Table 3 above, it can be confirmed that the content of 1-glycoside ginsenoside in hydroponic ginseng leaves is higher than that in ginseng leaves cultivated in the open field. Therefore, it can be confirmed that the use of hydroponic ginseng leaves can increase the 1-glycoside ginsenoside content compared to open field cultivation.
實施例3:分析根據蒸熟處理的人參葉人參皂苷含量Example 3: Analyze the ginsenoside content of ginseng leaves according to the steaming treatment
為了分析根據蒸熟處理的人參皂苷的其他醣苷的含量,旨在確定未經蒸熟處理的乾人參葉以及經蒸熟處理的人參葉的除1醣苷以外的其他醣苷的含量。具體而言,測量乾人參葉、蒸熟處理1次至2次的人參葉的低醣苷人參皂苷(1-醣苷人參皂苷)F1、化合物K、Rh2、Rh3、Rk2或除低醣苷以外的人參皂苷Rb1、Re、Rg1、F2、Rg3的含量,並示於下表4中。In order to analyze the content of other glycosides in the ginsenosides according to the steaming treatment, the aim was to determine the content of other glycosides other than 1 glycoside in dry ginseng leaves without steaming treatment and ginseng leaves after steaming treatment. Specifically, measure the low glycoside ginsenoside (1-glycosides ginsenoside) F1, compound K, Rh2, Rh3, Rk2, or ginsenosides other than low glycosides in dried ginseng leaves and ginseng leaves that have been steamed for 1 to 2 times The contents of Rb1, Re, Rg1, F2, and Rg3 are shown in Table 4 below.
[表4]
實施例4:分析紅參濃縮液以及經蒸熟處理的人參葉的1-醣苷人參皂苷含量Example 4: Analyze the content of 1-glycoside ginsenoside in red ginseng concentrate and steamed ginseng leaves
為了比較市售的紅參濃縮液和本發明的經蒸熟處理的人參葉的1-醣苷人參皂苷含量,旨在確定市售的正官庄紅參濃縮液1、市售的豐基人參紅參濃縮液2、市售的大同高麗參紅參濃縮液3和經蒸熟處理的人參葉的1-醣苷人參皂苷含量。具體實驗方法如下。In order to compare the 1-glycoside ginsenoside content of the commercially available red ginseng concentrate and the steamed ginseng leaves of the present invention, the aim was to determine the commercially available Zhengguanzhuang red ginseng concentrate 1, the commercially available Fengji ginseng red ginseng concentrate Liquid 2, the commercially available Datong Korean ginseng red ginseng concentrate 3 and the 1-glycoside ginsenoside content of the ginseng leaves after the steaming treatment. The specific experimental method is as follows.
如下表5所示,測量了紅參濃縮液1至3以及蒸熟處理人參葉的1-醣苷人參皂苷(1-glycoside ginsenoside)F1、化合物K、Rh2、Rh3或Rk2的含量。As shown in Table 5 below, the contents of 1-glycoside ginsenoside F1, compound K, Rh2, Rh3, or Rk2 of red ginseng concentrates 1 to 3 and steamed processed ginseng leaves were measured.
[表5]
如上表4至表5所示,將人參葉蒸熟組合物中發現的全部人參皂苷中大量含有的人參皂苷以及五種現有1-醣苷人參皂苷(1-glycoside ginsenoside)(F1、化合物K、Rh2、Rh3或Rk2)示於表4,並且添加表5以比較五種1-醣苷人參皂苷(F1、化合物K、Rh2、Rh3或Rk2),並且可以確認與乾人參葉以及市售的紅參濃縮液1至3相比,蒸熟處理人參葉中五種1-醣苷人參皂苷的含量較高。因此,可以確認藉由本發明選擇性地大量生產1-醣苷人參皂苷。As shown in Table 4 to Table 5 above, ginsenosides contained in large amounts in all ginsenosides found in the ginseng leaf steamed composition and five existing 1-glycoside ginsenosides (1-glycoside ginsenoside) (F1, compound K, Rh2) , Rh3 or Rk2) are shown in Table 4, and Table 5 is added to compare five 1-glycoside ginsenosides (F1, compound K, Rh2, Rh3 or Rk2), and it can be confirmed that it is concentrated with dried ginseng leaves and commercially available red ginseng Compared with liquid 1 to 3, the content of five 1-glycosides ginsenosides in steamed ginseng leaves was higher. Therefore, it can be confirmed that the 1-glycoside ginsenoside can be selectively produced in large quantities by the present invention.
實施例5:分析根據蒸熟處理時間的人參葉1-醣苷人參皂苷含量Example 5: Analysis of ginseng leaf 1-glycoside ginsenoside content according to steaming treatment time
旨在確定根據蒸熟處理時間的1-醣苷人參皂苷含量的變化。具體而言,將人參葉的蒸熟時間處理1小時至7小時,從而測量1-醣苷人參皂苷(1-glycoside ginsenoside)F1、化合物K、Rh2、Rh3或Rk2的含量。The aim was to determine the change in the content of 1-glycoside ginsenoside according to the steaming treatment time. Specifically, the steaming time of ginseng leaves is processed for 1 hour to 7 hours, thereby measuring the content of 1-glycoside ginsenoside F1, compound K, Rh2, Rh3, or Rk2.
[表6]
如上表6所示,可以確認1-醣苷人參皂苷(1-glycoside ginsenoside)F1、化合物K、Rh2、Rh3或Rk2的含量隨蒸熟處理時間而增加。然而,在將蒸熟處理時間處理5小時以上時,對含量沒有太大變化,因此,考慮到綜合效率,可以確認最佳蒸熟處理時間為5小時。As shown in Table 6 above, it can be confirmed that the content of 1-glycoside ginsenoside F1, compound K, Rh2, Rh3, or Rk2 increases with the steaming treatment time. However, when the steaming treatment time is more than 5 hours, the content does not change much. Therefore, considering the overall efficiency, it can be confirmed that the optimal steaming treatment time is 5 hours.
實驗例:人參葉濃縮液的抑制皮膚變黑的活性Experimental example: the activity of inhibiting skin darkening of ginseng leaf concentrate
為了確認本發明的人參葉濃縮液的抑制皮膚變黑的功效,在攝取人參葉濃縮液後確認了黑色素數值。具體的實驗方法如下。In order to confirm the effect of the ginseng leaf concentrate of the present invention in inhibiting skin darkening, the melanin value was confirmed after ingesting the ginseng leaf concentrate. The specific experimental method is as follows.
以黑斑為苦惱的30多歲至50多歲女性20名為對象,每天攝取3 g藉由上述製備例製備的人參葉濃縮液,並且在8周後使用黑色素皮膚檢測設備(Mexmeter)進行了關於有意地降低黑色素數值並改善黑斑的問卷調查。Twenty women in their 30s to 50s suffering from dark spots took 3 g of the ginseng leaf concentrate prepared by the above preparation example every day, and after 8 weeks, the test was performed using a melanin skin detection device (Mexmeter). Questionnaire about deliberately reducing melanin value and improving dark spots.
數值以及問卷調查結果,20名受試者的黑色素指數在8周後均降低,最終在8周後,對於評價功效性、對產品的好感度等的問卷,所有使用者對於受試者感受到的黑斑改善程度和對產品的總體滿意度等均回答為好以及非常好,從而確認了對所有受試者有效果。因此,藉由根據本發明的水耕栽培人參葉濃縮液,抑制皮膚變黑,從而可以期待皮膚美白改善效果。According to the numerical value and questionnaire survey results, the melanin index of 20 subjects decreased after 8 weeks, and finally after 8 weeks, for the questionnaires to evaluate the efficacy and favorability of the product, all users were The degree of spot improvement and overall satisfaction with the product were all answered as good and very good, thus confirming the effect on all subjects. Therefore, the hydroponic ginseng leaf concentrate according to the present invention suppresses skin darkening, and can expect skin whitening improvement effects.
綜上所述,本發明的水耕栽培人參葉濃縮液可以提供體內吸收率高的低醣苷人參皂苷(1-醣苷人參皂苷)的含量增加的人參葉濃縮液。另外,使用水耕栽培的人參葉進行蒸熟過程的本發明的人參葉濃縮液可以作為食品組合物以及皮膚美白用、黑斑改善用食品組合物而提供。In summary, the hydroponic cultivated ginseng leaf concentrate of the present invention can provide a ginseng leaf concentrate with increased content of low-glycoside ginsenoside (1-glycoside ginsenoside) with high absorption rate in the body. In addition, the ginseng leaf concentrate of the present invention, which uses hydroponic ginseng leaves for a steaming process, can be provided as a food composition and a food composition for skin whitening and dark spot improvement.
基於以上說明,本發明所屬技術領域的技術人員可以理解在沒有變更本發明的技術思想或者必要的特徵的情况下本發明還可以以其他具體方式實施。對此,應當理解,以上說明的實施例在所有的方面均為示例性的而非限制性的。本發明的範圍應被解釋為包括後述的申請專利範圍的意思以及範圍和從其等同概念導出的所有的變更或者變形的方式,而不僅僅包括上述的詳細說明。Based on the above description, those skilled in the art to which the present invention belongs can understand that the present invention can also be implemented in other specific ways without changing the technical idea or necessary features of the present invention. In this regard, it should be understood that the embodiments described above are illustrative and not restrictive in all aspects. The scope of the present invention should be construed as including the meaning and scope of the scope of patent application described later, and all changes or modifications derived from the equivalent concept thereof, and not only the above detailed description.
無without
無without
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200008819A KR20210094942A (en) | 2020-01-22 | 2020-01-22 | Food Composition Comprising Low-Glycosides Ginsenoside Using Hydroponically grown Ginseng Leaf |
KR10-2020-0008819 | 2020-01-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW202128028A true TW202128028A (en) | 2021-08-01 |
Family
ID=76882227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW109135060A TW202128028A (en) | 2020-01-22 | 2020-10-08 | Food composition comprising low-glycosides ginsenoside using hydroponically grown ginseng leaf and preparation method thereof |
Country Status (3)
Country | Link |
---|---|
KR (2) | KR20210094942A (en) |
CN (1) | CN113142580A (en) |
TW (1) | TW202128028A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102701784B1 (en) * | 2021-09-09 | 2024-09-03 | 주식회사 선샤인그린팜 | TEA of Panax ginseng sprout and method of preparing therefor |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100325778B1 (en) | 1999-07-20 | 2002-03-06 | 심건섭 | Method for Extraction of Ginseng Treated by Puffing Processing, and Health Foods Containing Said Extract |
KR100543862B1 (en) * | 2005-08-01 | 2006-01-23 | (주) 흑삼코리아 | A black ginseng having excel content of active ingredient and the concentrate of black ginseng |
KR20100043725A (en) * | 2008-10-21 | 2010-04-29 | 재단법인 홍천메디칼허브연구소 | Changes of protopanaxadiol ginsenosides in ginseng leaves by steaming heat treatment |
KR20100043723A (en) * | 2008-10-21 | 2010-04-29 | 재단법인 홍천메디칼허브연구소 | Changes of protopanaxadiol ginsenosides in ginseng leaves by far infrared heat treatment |
KR101173353B1 (en) * | 2010-03-16 | 2012-08-10 | (주)풀무원홀딩스 | Ginsenoside Re increased Red Ginseng Extract and method for preparing the same |
KR101416671B1 (en) * | 2011-12-26 | 2014-07-11 | 고성권 | Ginseng prosapogenin high concentration containing ginseng leaf or stem preparation using sonication and process for thereof |
KR101363074B1 (en) * | 2013-11-20 | 2014-02-14 | 남영제약영농조합법인 | Functional red ginseng or red ginseng powder with enhanced 21 type saponin and ginsenoside content and producing method thereof |
KR20150069663A (en) * | 2013-12-16 | 2015-06-24 | 주식회사 풀무원 | Improved manufacturing method of red ginseng concentrate for bitter taste |
KR20160058201A (en) * | 2014-10-22 | 2016-05-25 | 농업회사법인 자연드림 주식회사 | Manufacturing method of ginseng leaves powder cultured by hydroponics and ginseng leaves powder thereof |
KR101691334B1 (en) * | 2016-08-30 | 2016-12-29 | 최승 | Method for producing red ginseng extract with enhanced ginsenoside content, red ginseng extract and red ginseng processed-food thereof |
-
2020
- 2020-01-22 KR KR1020200008819A patent/KR20210094942A/en active Application Filing
- 2020-07-16 CN CN202010685983.2A patent/CN113142580A/en active Pending
- 2020-10-08 TW TW109135060A patent/TW202128028A/en unknown
-
2022
- 2022-12-26 KR KR1020220184682A patent/KR102497193B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR102497193B1 (en) | 2023-02-08 |
CN113142580A (en) | 2021-07-23 |
KR20210094942A (en) | 2021-07-30 |
KR20230005093A (en) | 2023-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3184628B1 (en) | Extract of panax ginseng including wild ginseng or ginseng, containing rare ginsenosides in high qunatity, plant stem cell derived from cambium of panax ginseng, or method for preparing extract thereof | |
KR101050821B1 (en) | Fermented black-red ginseng and the method of preparing it and fermented bellflower and fermented ginger | |
TWI648057B (en) | Composition for relieving premenstrual syndrome and menstrual pain | |
KR101362351B1 (en) | Ginseng process method for increasing ginsenoside quantity and processed goods thereof | |
Huang et al. | Recent progress on processing technologies, chemical components, and bioactivities of Chinese red ginseng, American red ginseng, and Korean red ginseng | |
KR102497193B1 (en) | Food Composition Comprising Low-Glycosides Ginsenoside Using Hydroponically grown Ginseng Leaf | |
CN108813501B (en) | Health-preserving honey paste with functions of clearing heat, moistening lung, relieving cough, reducing phlegm, relieving asthma and regulating human body functions | |
KR20160045347A (en) | Agent for Masking Bitterness of Ginseng and Ginseng Composition Containing the Same | |
KR102128411B1 (en) | Wood cultivated ginseng Matured solution and manufacturing method | |
KR102005031B1 (en) | The Ginseng-Berry extract including alcoholic liver injury prevention functional ingredients and method for manufacturing it | |
KR20160059137A (en) | MANUFACTURE OF FERMENTED Alliumhookeri FROM LACTIC ACID BACTERIA AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST | |
KR20150069663A (en) | Improved manufacturing method of red ginseng concentrate for bitter taste | |
KR101525877B1 (en) | A composition for preventing wrinkle of skin and anti aging of skin | |
KR101095357B1 (en) | Processed Ginseng | |
KR20130074119A (en) | Ginseng prosapogenin high concentration containing ginseng leaf or stem preparation using sonication and process for thereof | |
KR20150051811A (en) | Composition containing ginseng extract and ginseng fruit extract | |
KR101680294B1 (en) | Method for producing ginseng extract | |
KR102052530B1 (en) | Manufacturing Method of Fermented Red Ginseng Using Steamed Ginseng and Microorganism | |
KR20130085576A (en) | Preparation method for fermented ginseng berry extract | |
KR101723962B1 (en) | Atopic dermatitis mitigate functional composition using environmentally friendly natural ingredients | |
KR102627124B1 (en) | Manufacturing method of Jelly Stick using Wood Cultivated Ginseng | |
KR20130074118A (en) | Ginseng prosapogenin high concentration containing ginseng berry preparation using sonication and process for thereof | |
KR20130074120A (en) | Ginseng prosapogenin high concentration containing ginseng flower preparation using sonication and process for thereof | |
CN110024928A (en) | A kind of jujube beverage and its preparation process | |
KR101370577B1 (en) | A beverage composition using sponges and cabbage and its manufacturing method |